Latest Insights into Mechanisms behind Atrial Cardiomyopathy: It Is Not always about Ventricular Function

Nagle, 1972, Familial atrial cardiomyopathy with heart block, Br. Heart J., 34, 205

Goette, 2016, EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication, Europace, 18, 1455, 10.1093/europace/euw161

Bukowska, 2019, Clinical importance of atrial cardiomyopathy, Int. J. Cardiol., 287, 174, 10.1016/j.ijcard.2018.11.121

Darlington, 2020, Atrial cardiomyopathy: An unexplored limb of virchow’s triad for AF stroke prophylaxis, Front. Cardiovasc. Med., 7, 11, 10.3389/fcvm.2020.00011

Hoit, 2014, Left atrial size and function: Role in prognosis, J. Am. Coll. Cardiol., 63, 493, 10.1016/j.jacc.2013.10.055

Nattel, 2008, Atrial remodeling and atrial fibrillation: Mechanisms and implications, Circ. Arrhythm. Electrophysiol., 1, 62, 10.1161/CIRCEP.107.754564

Thomas, 2017, Left Atrial reverse remodeling: Mechanisms, evaluation, and clinical significance, JACC Cardiovasc. Imaging, 10, 65, 10.1016/j.jcmg.2016.11.003

Dilaveris, 2018, Biomarkers associated with atrial fibrosis and remodeling, Curr. Med. Chem., 26, 780, 10.2174/0929867324666170918122502

Dzeshka, 2015, Cardiac fibrosis in patients with atrial fibrillation: Mechanisms and clinical implications, J. Am. Coll. Cardiol., 66, 943, 10.1016/j.jacc.2015.06.1313

Hirsh, 2015, Fibrotic atrial cardiomyopathy, atrial fibrillation, and thromboembolism: Mechanistic links and clinical inferences, J. Am. Coll. Cardiol., 65, 2239, 10.1016/j.jacc.2015.03.557

Jalife, 2015, Atrial remodeling, fibrosis, and atrial fibrillation, Trends Cardiovasc. Med., 25, 475, 10.1016/j.tcm.2014.12.015

Tarone, 2014, Targeting myocardial remodelling to develop novel therapies for heart failure, Eur. J. Heart Fail., 16, 494, 10.1002/ejhf.62

Korantzopoulos, 2018, Inflammation and atrial fibrillation: A comprehensive review, J. Arrhythm., 34, 394, 10.1002/joa3.12077

Pandit, 2016, Atrial electrophysiological remodeling and fibrillation in heart failure, Clin. Med. Insights Cardiol., 10, 41

Shen, 2019, Atrial Myopathy, JACC Basic Transl. Sci., 4, 640, 10.1016/j.jacbts.2019.05.005

Xu, 2013, Atrial remodeling: New pathophysiological mechanism of atrial fibrillation, Med. Hypotheses, 80, 53, 10.1016/j.mehy.2012.10.009

Nattel, 2014, Atrial remodeling and atrial fibrillation: Recent advances and translational perspectives, J. Am. Coll. Cardiol., 63, 2335, 10.1016/j.jacc.2014.02.555

Medi, 2011, Atrial electrical and structural changes associated with longstanding hypertension in humans: Implications for the substrate for atrial fibrillation, J. Cardiovasc. Electrophysiol., 22, 1317, 10.1111/j.1540-8167.2011.02125.x

Melenovsky, 2015, Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction, Circ. Heart Fail., 8, 295, 10.1161/CIRCHEARTFAILURE.114.001667

Sonmez, 2014, Novel fibro-inflammation markers in assessing left atrial remodeling in non-valvular atrial fibrillation, Med. Sci. Monit., 20, 463, 10.12659/MSM.890635

Tadic, 2015, The influence of type 2 diabetes on left atrial remodeling, Clin. Cardiol., 38, 48, 10.1002/clc.22334

Sciacqua, 2014, Renal disease and left atrial remodeling predict atrial fibrillation in patients with cardiovascular risk factors, Int. J. Cardiol., 175, 90, 10.1016/j.ijcard.2014.04.259

Dimitri, 2012, Atrial remodeling in obstructive sleep apnea: Implications for atrial fibrillation, Heart Rhythm, 9, 321, 10.1016/j.hrthm.2011.10.017

Guichard, 2017, Atrial cardiomyopathy: A useful notion in cardiac disease management or a passing fad?, J. Am. Coll. Cardiol., 70, 756, 10.1016/j.jacc.2017.06.033

Maass, 2011, Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation, Cardiovasc. Res., 89, 754, 10.1093/cvr/cvq357

Patel, 2009, Clinical implications of left atrial enlargement: A review, Ochsner J., 9, 191

Takemoto, 2005, Usefulness of left atrial volume in predicting first congestive heart failure in patients ≥ 65 years of age with well-preserved left ventricular systolic function, Am J Cardiol., 96, 832, 10.1016/j.amjcard.2005.05.031

Kogawa, 2017, Left atrial remodeling: Regional differences between paroxysmal and persistent atrial fibrillation, J. Arrhythm., 33, 483, 10.1016/j.joa.2017.06.001

Kottkamp, 2013, Human atrial fibrillation substrate: Towards a specific fibrotic atrial cardiomyopathy, Eur. Heart J., 34, 2731, 10.1093/eurheartj/eht194

Teh, 2012, Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease, J. Cardiovasc. Electrophysiol., 23, 232, 10.1111/j.1540-8167.2011.02178.x

Stiles, 2009, Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate, Characterizing the “Second Factor”. J. Am. Coll. Cardiol., 53, 1182, 10.1016/j.jacc.2008.11.054

Staerk, 2017, Atrial fibrillation: Epidemiology, pathophysiology, and clinical outcomes, Circ. Res., 120, 1501, 10.1161/CIRCRESAHA.117.309732

Kamel, 2017, Cardioembolic stroke, Circ. Res., 120, 514, 10.1161/CIRCRESAHA.116.308407

Fu, 2018, Association between left atrial enlargement and obstructive sleep apnea in a general population of 71-year-old men, J. Sleep Res., 27, 252

Cresti, 2015, Atrial fibrillation in patients with diabetes: Molecular mechanisms and therapeutic perspectives, Cardiovasc. Diagn. Ther., 5, 364

Poulsen, 2013, Left atrial volume index: Relation to long-term clinical outcome in type 2 diabetes, J. Am. Coll. Cardiol., 62, 2416, 10.1016/j.jacc.2013.08.1622

Aiad, 2019, Mechanisms of left atrial enlargement in obesity, Am. J. Cardiol., 124, 442, 10.1016/j.amjcard.2019.04.043

Wang, 2019, Moderate chronic kidney disease and left atrial enlargement independently predict thromboembolic events and mortality in elderly patients with atrial fibrillation: A retrospective single-center study, J. Int. Med. Res., 47, 4312, 10.1177/0300060519858151

Acampa, 2018, Atrial cardiopathy and sympatho-vagal imbalance in cryptogenic stroke: Pathogenic mechanisms and effects on electrocardiographic markers, Front. Neurol., 9, 469, 10.3389/fneur.2018.00469

Hohnloser, 2006, Asymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT), Am. Heart J., 152, 442, 10.1016/j.ahj.2006.02.016

Santema, 2020, The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure, Clin. Res. Cardiol., 109, 331, 10.1007/s00392-019-01513-y

Forte, M., Madonna, M., Schiavon, S., Valenti, V., Versaci, F., Zoccai, G.B., Frati, G., and Sciarretta, S. (2019). Cardiovascular pleiotropic effects of natriuretic peptides. Int. J. Mol. Sci., 20.

Song, 2015, Atrial natriuretic peptide in cardiovascular biology and disease (NPPA), Gene, 569, 1, 10.1016/j.gene.2015.06.029

Denysiak, 2016, Elevated ST2 is associated with more extensive atrial remodeling and longer ablation procedure duration in patients with atrial fibrillation and flutter, Circulation, 134, A19839

Miftode, R.S., Petriș, A.O., Onofrei Aursulesei, V., Cianga, C., Costache, I.I., Mitu, O., Miftode, I.L., and Șerban, I.L. (2021). The novel perspectives opened by st2 in the pandemic: A review of its role in the diagnosis and prognosis of patients with heart failure and COVID-19. Diagnostics, 11.

Miftode, 2019, Syndecan-1: A review on its role in heart failure and chronic liver disease patients’ assessment, Cardiol. Res. Pract., 2019, 4750580, 10.1155/2019/4750580

Floria, M., Radu, S., Gosav, E.M., Cozma, D., Mitu, O., Ouatu, A., Tanase, D.M., Scripcariu, V., and Serban, L.I. (2020). Left atrial structural remodelling in non-valvular atrial fibrillation: What have we learnt from CMR?. Diagnostics, 10.

Mahajan, 2018, Electroanatomical Remodeling of the Atria in Obesity: Impact of Adjacent Epicardial Fat, JACC Clin. Electrophysiol., 4, 1529, 10.1016/j.jacep.2018.08.014

Nakamori, 2018, Left Atrial Epicardial Fat Volume Is Associated With Atrial Fibrillation: A Prospective Cardiovascular Magnetic Resonance 3D Dixon Study, J. Am. Heart Assoc., 7, e008232, 10.1161/JAHA.117.008232

Doesch, 2013, Epicardial adipose tissue assessed by cardiac magnetic resonance imaging in patients with heart failure due to dilated cardiomyopathy, Obesity, 21, E253, 10.1002/oby.20149

Wong, 2017, Epicardial fat and atrial fibrillation: Current evidence, potential mechanisms, clinical implications, and future directions, Eur. Heart J., 38, 1294

Welles, 2010, Pericardial fat is independently associated with human atrial fibrillation, J. Am. Coll. Cardiol., 56, 784, 10.1016/j.jacc.2010.03.071

Thanassoulis, 2010, Pericardial fat is associated with prevalent atrial fibrillation: The Framingham Heart Study, Circ. Arrhythm. Electrophysiol., 3, 345, 10.1161/CIRCEP.109.912055

Lu, 2020, Effects of epicardial adipose tissue volume and density on cardiac structure and function in patients free of coronary artery disease, Jpn. J. Radiol, 38, 666, 10.1007/s11604-020-00951-3

Ellermann, 2018, Ranolazine prevents levosimendan-induced atrial fibrillation, Pharmacology, 102, 138, 10.1159/000490572

Shao, 2019, Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats, Cardiovasc. Diabetol., 18, 165, 10.1186/s12933-019-0964-4

Cangemi, 2012, Different behaviour of NOX2 activation in patients with paroxysmal/persistent or permanent atrial fibrillation, Heart, 98, 1063, 10.1136/heartjnl-2012-301952

Mihm, 2001, Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation, Circulation, 104, 174, 10.1161/01.CIR.104.2.174

Nishinarita, 2021, Canagliflozin Suppresses Atrial Remodeling in a Canine Atrial Fibrillation Model, J. Am. Heart Assoc., 10, e017483, 10.1161/JAHA.119.017483

Mudaliar, 2016, Can a shift in fuel energetics explain the beneficial cardiorenal outcomes in the EMPA-REG OUTCOME study? A unifying hypothesis, Diabetes Care, 39, 1115, 10.2337/dc16-0542

Alexander, 2017, Reverse atrial electrical remodeling induced by cardiac resynchronization therapy, J. Electrocardiol., 50, 610, 10.1016/j.jelectrocard.2017.04.015

Ypenburg, 2007, Acute effects of initiation and withdrawal of cardiac resynchronization therapy on papillary muscle dyssynchrony and mitral regurgitation, J. Am. Coll. Cardiol., 50, 2071, 10.1016/j.jacc.2007.08.019

Plappert, 2003, Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure, Circulation, 107, 1985, 10.1161/01.CIR.0000065226.24159.E9

Mathias, 2016, Clinical implications of complete left-sided reverse remodeling with cardiac resynchronization therapy: A MADIT-CRT substudy, J. Am. Coll. Cardiol., 68, 1268, 10.1016/j.jacc.2016.06.051

Hawkins, 2018, Postoperative atrial fibrillation is associated with increased morbidity and resource utilization after left ventricular assist device placement, J. Thorac. Cardiovasc. Surg., 156, 1543, 10.1016/j.jtcvs.2018.03.169

Hickey, 2016, Atrial fibrillation in patients with left ventricular assist devices: Incidence, predictors, and clinical outcomes, JACC Clin. Electrophysiol., 2, 793, 10.1016/j.jacep.2016.03.009

Deshmukh, 2017, Atrial arrhythmias and electroanatomical remodeling in patients with left ventricular assist devices, J. Am. Heart Assoc., 6, e005340, 10.1161/JAHA.116.005340

Beukema, 2005, Successful radiofrequency ablation in patients with previous atrial fibrillation results in a significant decrease in left atrial size, Circulation, 112, 2089, 10.1161/CIRCULATIONAHA.104.484766

Reant, 2005, Reverse remodeling of the left cardiac chambers after catheter ablation after 1 year in a series of patients with isolated atrial fibrillation, Circulation, 112, 2896, 10.1161/CIRCULATIONAHA.104.523928

Tops, 2006, Effect of radiofrequency catheter ablation for atrial fibrillation on left atrial cavity size, Am. J. Cardiol., 97, 1220, 10.1016/j.amjcard.2005.11.043

Kagawa, 2020, Association between left atrial reverse remodeling and maintenance of sinus rhythm after catheter ablation of persistent atrial fibrillation, Heart Vessel., 35, 239, 10.1007/s00380-019-01475-1

Aronis, 2019, The role of personalized atrial modeling in understanding atrial fibrillation mechanisms and improving treatment, Int. J. Cardiol., 287, 139, 10.1016/j.ijcard.2019.01.096

Trayanova, 2014, Mathematical approaches to understanding and imaging atrial fibrillation: Significance for mechanisms and management, Circ. Res., 114, 1516, 10.1161/CIRCRESAHA.114.302240

Ni, 2017, Synergistic anti-arrhythmic effects in human atria with combined use of sodium blockers and acacetin, Front. Physiol., 8, 946, 10.3389/fphys.2017.00946

Vagos, 2018, Computational Modeling of Electrophysiology and Pharmacotherapy of Atrial Fibrillation: Recent Advances and Future Challenges, Front. Physiol., 9, 1221, 10.3389/fphys.2018.01221